Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Congruence Therapeutics Series A round, February 8, 2022
Congruence Therapeutics raised a Series A round for 50,000,000 USD in February, 2022.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 21 Jan, 2023
Semyon Kolychev
edited on 21 Jan, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Date Announced
February 8, 2022
0
Funded Company
Congruence Therapeutics
0
Funding Round Amount (USD)
50,000,000
0
Funding Type
Series A
0
Investment
Fonds de solidarité FTQ
0
OrbiMed
0
Investissement Quebec
0
Lumira Ventures
0
Driehaus Capital Management
0
Amplitude Ventures
0
Funding Round Date
February 8, 2022
0
Edits on 27 Jun, 2022
Semyon Kolychev
edited on 27 Jun, 2022
Edits made to:
Infobox
(
+7
properties)
Infobox
Announcement URL
https://www.prnewswire.com/news-releases/congruence-therapeutics-inc-announces-us50-million-series-a-financing-to-advance-platform-targeting-diseases-of-protein-misfolding-301477560.html
Investment
Fonds de solidarité FTQ
OrbiMed
Investissement Quebec
Lumira Ventures
Driehaus Capital Management
Amplitude Ventures
"Created via: Web app"
Semyon Kolychev
created this topic on 27 Jun, 2022
Edits made to:
Infobox
(
+5
properties)
Congruence Therapeutics Series A round, February 8, 2022
Infobox
Is a
Funding round
Funding type
Series A
Funded company
Congruence Therapeutics
Funding round amount (USD)
50,000,000
Date announced
February 8, 2022
Find more entities like Congruence Therapeutics Series A round, February 8, 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE